| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-01-26 | emixustat | macular atrophy secondary to Stargardt disease | 2 | Acucela (USA - MA) | Rare diseases - Genetic diseases - Ophtalmological diseases |
| 2017-01-25 | relugolix | heavy menstrual bleeding associated with uterine fibroids | 3 | Myovant Sciences (Switzerland) | Women health |
| 2017-01-25 | BGB-3111 | Waldenström’s macroglobulinemia | 3 | BeiGene (China) | Cancer - Oncology |
| 2017-01-25 | ABBV-8E12/C2N-8E12 | Alzheimer's Disease | 2 | Abbvie (USA - IL) | Neurodegenerative diseases |
| 2017-01-25 | ABBV-8E12/C2N-8E12 | progressive supranuclear palsy | 2 | AbbVie | Rare diseases - Neurodegenerative diseases - Neurological diseases |
| 2017-01-25 | IFN alpha Kinoid | type 1 diabetes | preclinical | Neovacs (France) | Autoimmune diseases - Metabolic diseases |
| 2017-01-24 | resminostat (oral pan-histone deacetylase (HDAC) inhibitor) | hepatocellular carcinoma (HCC) | 2 | Yakult Honsha (Japan) 4SC (Germany) | Cancer - Oncology |
| 2017-01-24 | TPIV 200 (multi-epitope folate receptor alpha peptide vaccine with GM-CSF adjuvant) and durvalumab | ovarian cancer | 2 | Memorial Sloan Kettering Cancer Center (USA - NY) AstraZeneca (UK) Tapimmune (USA - Fl) | Cancer - Oncology |
| 2017-01-23 | Vectibix® (panitumumab) | chemorefractory wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC)/p> | 3 | Amgen (USA - CA) | Cancer - Oncology |
| 2017-01-23 | CAR T-cell therapy | preclinical | Cellectis (France) | ||
| 2017-01-20 | CA4P (fosbretabulin tromethamine) | unresectable, recurrent or metastatic pancreatic or gastrointestinal neuroendocrine tumors | 2 | Mateon Therapeutics (USA - CA), previously known as Oxigene (USA - CA) | Cancer - Oncology |
| 2017-01-20 | IPI-549 | preclinical | Infinity Pharmaceuticals (USA - MA) | Cancer - Oncology | |
| 2017-01-20 | IMP321 | metastatic breast cancer | 2b | Prima Biomed (Australia) | Cancer - Oncology |
| 2017-01-19 | Cimzia® (certolizumab pegol) | psoriasis | 3 | UCB (Belgium) | Autoimmune diseases - Dermatological diseases |
| 2017-01-19 | Opdivo® (nivolumab) | gastric cancer | 3 | Ono Pharmaceutical (Japan) BMS (USA - NY) | Cancer - Oncology |
| 2017-01-18 | GBT440 | sickle cell disease | 3 | Global Blood Therapeutics (USA - CA) | Rare diseases - Genetic diseases - Hematological diseases |
| 2017-01-18 | GX-G6 | type 2 diabetes | 1 | Genexine (Republic of Korea) | Metabolic diseases |
| 2017-01-17 | SFX-01 | breast cancer | 1-2 | Evgen Pharma (UK) | Cancer - Oncology |
| 2017-01-17 | ulipristal acetate | uterine fibroids | 3 | Gedeon Richter (Hungary) Allergan (Ireland) | Gynecology - Women's health |
| 2017-01-17 | Xilonix™ | advanced colorectal cancer | 3 | XBiotech (USA - TX) | Cancer - Oncology |
